As of Jun 21
| +0.06 / +0.08%|
The 20 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 85.50, with a high estimate of 105.00 and a low estimate of 69.00. The median estimate represents a +19.55% increase from the last price of 71.52.
The current consensus among 26 polled investment analysts is to Buy stock in Gilead Sciences Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.